HomeCompareCBD vs EQR

CBD vs EQR: Dividend Comparison 2026

CBD yields 449.44% · EQR yields 5.87%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CBD wins by $208.4K in total portfolio value
10 years
CBD
CBD
● Live price
449.44%
Share price
$0.45
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$256.2K
Annual income
$570.39
Full CBD calculator →
EQR
EQR
● Live price
5.87%
Share price
$59.15
Annual div
$3.47
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47.8K
Annual income
$5,475.61
Full EQR calculator →

Portfolio growth — CBD vs EQR

📍 CBD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCBDEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CBD + EQR cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CBD pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CBD
Annual income on $10K today (after 15% tax)
$38,202.25/yr
After 10yr DRIP, annual income (after tax)
$484.83/yr
EQR
Annual income on $10K today (after 15% tax)
$499.01/yr
After 10yr DRIP, annual income (after tax)
$4,654.27/yr
At 15% tax rate, EQR beats the other by $4,169.44/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CBD + EQR for your $10,000?

CBD: 50%EQR: 50%
100% EQR50/50100% CBD
Portfolio after 10yr
$152.0K
Annual income
$3,023.00/yr
Blended yield
1.99%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

CBD
Analyst Ratings
3
Buy
3
Hold
Consensus: Buy
Altman Z
1.1
Piotroski
4/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+18.9% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CBD buys
0
EQR buys
0
No recent congressional trades found for CBD or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCBDEQR
Forward yield449.44%5.87%
Annual dividend / share$2.00$3.47
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%15.8%
Portfolio after 10y$256.2K$47.8K
Annual income after 10y$570.39$5,475.61
Total dividends collected$149.0K$23.0K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyHold

Year-by-year: CBD vs EQR ($10,000, DRIP)

YearCBD PortfolioCBD Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$33,172$22,471.91$11,380$679.82+$21.8KCBD
2$70,327$34,833.47$13,014$837.25+$57.3KCBD
3$109,760$34,509.37$14,961$1,036.20+$94.8KCBD
4$142,610$25,167.59$17,297$1,289.22+$125.3KCBD
5$167,874$15,280.46$20,121$1,613.15+$147.8KCBD
6$188,030$8,405.31$23,561$2,030.84+$164.5KCBD
7$205,592$4,399.31$27,783$2,573.54+$177.8KCBD
8$222,231$2,247.75$33,013$3,284.39+$189.2KCBD
9$238,922$1,135.36$39,547$4,223.51+$199.4KCBD
10$256,217$570.39$47,791$5,475.61+$208.4KCBD

CBD vs EQR: Complete Analysis 2026

CBDStock

Companhia Brasileira de Distribuição engages in the retail of food, clothing, home appliances, electronics, and other products through its chain of supermarkets, specialized stores, and department stores in Brazil. It operates in Brazilian Retail, Grupo Éxito, and Other Businesses segments. The company sells non-perishables, beverages, fruits, vegetables, meat, breads, cold cuts, dairy products, cleaning products, disposable products, and personal care products; and home appliances and other non-food products, such as clothing and baby items, shoes and accessories, household articles, books, magazines, CDs and DVDs, stationery, toys, sports and camping gears, furniture, mobile phones, mattresses, pet products, and gardening equipment and tools, as well as electronic products, including personal computers, software, computer accessories, and sound and image systems. It also offers medications and cosmetics at its drugstores; and non-food products at gas stations, as well as rents commercial spaces and e-commerce sales. The company operates its supermarkets under the banners of Pão de Açúcar, Extra Supermercado, Mercado Extra, and Compre Bem; hypermarkets under the banner of Extra Hiper; and proximity stores under the banners of Mini Extra, Minuto Pão de Açúcar, Pão de Açúcar Adega, and Aliados Minimercado; and gas stations and drugstores under the banners of Extra and Pão de Açúcar, as well as sells its products through its Websites. As of December 31, 2021, it operated 667 stores, 74 gas stations, and 68 drugstores in 16 Brazilian states and the Federal District, as well as 15 distribution centers and warehouses across Brazil. The company was founded in 1948 and is headquartered in São Paulo, Brazil.

Full CBD Calculator →

EQRREIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this CBD vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CBD vs SCHDCBD vs JEPICBD vs OCBD vs KOCBD vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.